title: Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
abstract: These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of live, attenuated varicella virus vaccine--VARIVAX--manufactured by Merck and Company, Inc. and licensed in March 1995 for use in healthy persons > or = 12 months of age. In addition to presenting information regarding vaccine, this statement updates previous recommendations concerning the use of varicella zoster immune globulin (VZIG) as prophylaxis against varicella (MMWR 1984; 33:84-90, 95-100).
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000627:therapeutic use; D002644:Chickenpox / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D019433:Chickenpox Vaccine; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D003362:Cost-Benefit Analysis; D003428:Cross Infection; D004356:Drug Storage; D005260:Female; D006562:Herpes Zoster / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage / Q000009:adverse effects; D007116:Immunization, Passive / Q000592:standards; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008875:Middle Aged; D011247:Pregnancy; D011358:Product Surveillance, Postmarketing; D012698:Serologic Tests; D014611:Vaccination / Q000009:adverse effects / Q000191:economics / Q000592:standards*; D014613:Vaccines, Attenuated; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000276:immunology / Q000600:supply & distribution
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents; D019433:Chickenpox Vaccine; D007106:Immune Sera; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; C030799:varicella-zoster immune globulin; D000212:Acyclovir